InDex Pharmaceuticals Holding AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Johan Giléus, was filed 24 Feb 2023.
InDex Pharmaceuticals Holding AB: what insiders have been doing
Every trade that managers of InDex Pharmaceuticals Holding AB disclose to Finansinspektionen is tracked on this page. No insider at InDex Pharmaceuticals Holding AB has published a filing in the past twelve months. The most recent one dates from 14 July 2023.
Looking back to 2016, when coverage begins, insiders filed 25 purchases and 2 sales.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
- 1,930,700 shares0OptionFI:csv-769d87742ad2f0323a86
- 772,300 shares0OptionFI:csv-2d98fadfee6c99e07eec
- 150,000 shares@ SEK 0.4410.8% of flowAktieISIN SE0008966295FI:csv-ebe1c7c826618cd7545fCanonical exit: 25 May 2023 (T+90)
- 121,951 shares@ SEK 0.41100.0% of flowAktieISIN SE0008966295FI:csv-b4e87da591596a628da1Canonical exit: 24 May 2023 (T+90)
- 155,000 shares@ SEK 0.4234.5% of flowAktieISIN SE0015503388FI:csv-56965c8db0b88ca352b1Canonical exit: 24 May 2023 (T+90)
- 772,300 shares0OptionFI:csv-680960881a2a8311a2b2
- 1,930,700 shares0OptionFI:csv-bd4aeeea19dfa22f8536
- 772,300 shares0OptionFI:csv-49d055a1e550ee21527c
- 340,000 shares@ SEK 1.2050.5% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-b28801875b20d89d2c56
- 319,810 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-1c7e19f0732233bfcb1e
- 319,810 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-080d70cf322d6f39be82
- 406,120 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-930d5914ef3860522fdb
- 550,000 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-88571d2701fa8c592b4a
- 550,000 shares@ SEK 1.2051.5% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-928310698932d5144bd0
- 102,500 shares@ SEK 1.2068.4% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-58db3c1f132add107b9d
- 102,500 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-ef2ad60dfdea69ab3f0e
- 340,000 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-96438052aff074485bcb
- 406,120 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-dfc526224258aa9df70f
- 81,224 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-75cad58e87e9e9462b30
- 94,500 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)FI:csv-4d59341dde327e6fbb63
- 360,000 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-30ce077e665433d0c0b3
- 360,000 shares@ SEK 1.2070.3% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-a3358d6d7fb9e0b54dc9
- 200,000 shares@ SEK 1.2047.9% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-298a7e30882fffcf4f77
- 200,000 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-a040116f24cd95cfa325
- 17,500 shares@ SEK 8.6624.0% of flowAktieISIN SE0008966295FI:csv-97a9fb9c306afbd81855Canonical exit: 24 Nov 2020 (T+90)
25 of 54 declarations
About InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB is a Swedish biopharmaceutical company focused on developing treatments for inflammatory bowel diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations